Anticorps Polyclonal de lapin anti-TERF2

• Phare
• Validé par KD/KO

TERF2 Polyclonal Antibody for WB, IP, IHC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IP, IHC, ELISA

Conjugaison

Non conjugué

Publications

2

N° de cat : 22020-1-AP

Synonymes

Telomeric DNA binding protein, TERF2, TRBF2, TRF2, TTAGGG repeat binding factor 2

---

Galerie de données de validation

• 

  WB analysis of Jurkat using 22020-1-AP

  Jurkat cells were subjected to SDS PAGE followed by western blot with 22020-1-AP (TERF2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis using 22020-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 22020-1-AP (TERF2 antibody) at dilution of 1:6000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of K-562 using 22020-1-AP

  K-562 cells were subjected to SDS PAGE followed by western blot with 22020-1-AP (TERF2 antibody) at dilution of 1:500 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HeLa using 22020-1-AP

  HeLa cells were subjected to SDS PAGE followed by western blot with 22020-1-AP (TERF2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of MCF-7 using 22020-1-AP

  MCF7 cells were subjected to SDS PAGE followed by western blot with 22020-1-AP (TERF2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of NIH/3T3 using 22020-1-AP

  NIH/3T3 cells were subjected to SDS PAGE followed by western blot with 22020-1-AP (TERF2 antibody) at dilution of 1:1000 incubated at room temperature for 1.5 hours.

• 

  IP experiment of K-562 using 22020-1-AP

  IP result of anti-TERF2 (IP:22020-1-AP, 4ug; Detection:22020-1-AP 1:500) with K-562 cells lysate 4000ug.

• 

  IHC staining of human gliomas using 22020-1-AP

  Immunohistochemical analysis of paraffin-embedded human gliomas tissue slide using 22020-1-AP (TERF2 antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of human gliomas using 22020-1-AP

  Immunohistochemical analysis of paraffin-embedded human gliomas tissue slide using 22020-1-AP (TERF2 antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of rat brain using 22020-1-AP

  Immunohistochemical analysis of paraffin-embedded rat brain tissue slide using 22020-1-AP (TERF2 antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of rat brain using 22020-1-AP

  Immunohistochemical analysis of paraffin-embedded rat brain tissue slide using 22020-1-AP (TERF2 antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of mouse brain using 22020-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse brain tissue slide using 22020-1-AP (TERF2 antibody) at dilution of 1:200 (under 40x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

• 

  IHC staining of mouse brain using 22020-1-AP

  Immunohistochemical analysis of paraffin-embedded mouse brain tissue slide using 22020-1-AP (TERF2 antibody) at dilution of 1:200 (under 10x lens). Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0).

---

Applications testées

• Résultats positifs en WB: cellules HeLa, cellules Jurkat, cellules K-562, cellules MCF-7, cellules NIH/3T3
• Résultats positifs en IP: cellules K-562
• Résultats positifs en IHC: tissu de gliome humain, tissu cérébral de rat, tissu cérébral de souris; il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0.

Dilution recommandée

• Western Blot (WB): WB : 1:2000-1:12000
• Immunoprécipitation (IP): IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
• Immunohistochimie (IHC): IHC : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Applications publiées

• KD/KO: See 1 publications below
• WB: See 2 publications below

Informations sur le produit

22020-1-AP cible TERF2 dans les applications de WB, IP, IHC, ELISA et montre une réactivité avec des échantillons Humain, rat, souris

• Réactivité: Humain, rat, souris
• Réactivité citée: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: TERF2 Protéine recombinante Ag16798
• Nom complet: telomeric repeat binding factor 2
• Masse moléculaire calculée: 56 kDa
• Poids moléculaire observé: 65-69 kDa
• Numéro d’acquisition GenBank: BC024890
• Symbole du gène: TERF2
• Identification du gène (NCBI): 7014
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3
• Conditions de stockage: Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20^oC Les 20ul contiennent 0,1% de BSA.

Informations générales

TRF2, also named as TRBF2 and Telomeric repeat-binding factor 2, is a 542 amino acid protein, which contains 1 HTH myb-type DNA-binding domain and localizes in the Nucleus. TRF2 binds the telomeric double-stranded 5'-TTAGGG-3' repeat and plays a central role in telomere maintenance and protection against end-to-end fusion of chromosomes. TRF2 is a component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. TRF2 together with DCLRE1B/Apollo, is required to control the amount of DNA topoisomerase (TOP1, TOP2A and TOP2B), which is needed for telomere replication during fork passage and prevent aberrant telomere topology. TRF2 recruits TERF2IP/RAP1 to telomeres, thereby participating in to repressing homology-directed repair (HDR), which can affect telomere length.

Publications

Species	Application	Title
human	WB	Oxid Med Cell Longev; Inhibition of TRF2 Leads to Ferroptosis, Autophagic Death, and Apoptosis by Causing Telomere Dysfunction; Authors - Qiuhui Yang ; KD Validated
human	WB	Cell Mol Biol Lett; MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer; Authors - Wanjun Liu